Alia Therapeutics
5 known investors
Alia Therapeutics is a gene editing company developing genetic medicines aimed at curing genetic diseases. It focuses on unlocking new targets, tissues, and therapeutic windows to reach genomic sites that are currently inaccessible.
Investors · 5
Also in the syndicate · 3
Banca ProfiloBanor SIMIndaco Bio
Funding
SEC filings, press & company announcements- Undisclosed amountseed financing extensionApr 2023
Sofinnova Partners (lead), Banca Profilo, Banor SIM, Indaco Bio
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Alia Therapeutics do?
- Alia Therapeutics is a gene editing company developing genetic medicines aimed at curing genetic diseases. It focuses on unlocking new targets, tissues, and therapeutic windows to reach genomic sites that are currently inaccessible.
- Who are Alia Therapeutics's investors?
- Alia Therapeutics's investors include Indaco Venture Partners, Sofinnova Partners.